Research Article

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii

Table 2

Antibiotic Susceptibility Testing for Pseudomonas spp.

Antimicrobial agentPseudomonas spp.
P1P2P3P4P5
(mm)S-I-R (mm)S-I-R (mm)S-I-R (mm)S-I-R (mm)S-I-R

Imipenem 22S23S25S9R11R
Meropenem 14S18S31S14R8R
Aztreonam 21I14R26S22S19I
Ceftazidime 22S14R26S20S13R
Gentamycin 19S6R24S15S15S
Ciprofloxacin 30S6R25S24S14R
Piperacillin/Tazobactam 25S20S26S21S13R
Piperacillin 23S17R11R21S12R
Tobramycin 21S7R24S17S19S
Amikacin 23S17S22S17S17S
Trimethoprim Sulfamethoxazole 6R6R12R6R6R

“S” stands for susceptible, “I” for intermediate resistance, and “R” for resistant. “” stands for diameter of inhibition zone. P1 through P5 represent the 5 Pseudomonas spp. strains studied. The test was done according to CLSI guidelines.